抗生素耐药性
斯科普斯
抗菌剂
抗性(生态学)
大流行
抗药性
临床微生物学
医学
梅德林
2019年冠状病毒病(COVID-19)
抗生素
生物
微生物学
内科学
传染病(医学专业)
生态学
生物化学
疾病
作者
Avinash Sharma,Alfonso J. Rodríguez‐Morales,Tieble Traore,Shuja Shafi,Sherif A El-Kafrawi,Esam I. Azhar,Alimuddin Zumla
出处
期刊:The Lancet
[Elsevier]
日期:2022-11-16
卷期号:402 (10398): e5-e7
被引量:13
标识
DOI:10.1016/s0140-6736(22)01995-x
摘要
Antimicrobial resistance is associated with an estimated 4·95 million deaths annually and is currently a leading cause of death worldwide.1 Despite numerous global initiatives to control the surge of antimicrobial resistance, at the current rate of increase, annual deaths from antimicrobial resistance are estimated to rise to 10 million by 2050. This puzzling conundrum indicates that there are unknown factors that continue to increase antimicrobial resistance at a global scale and that identifying them will be crucial in controlling the ongoing antimicrobial resistance pandemic.
科研通智能强力驱动
Strongly Powered by AbleSci AI